1887

Abstract

Little is known of the relationships among paediatric upper gastrointestinal microbiotas, and the impact of medication use and disease on their diversity. Here, we investigated the diversity of three microbiotas in the upper gastrointestinal tract of paediatric patients in relation to each other and to host factors. Oral, oesophageal and gastric microbiotas from a prospective paediatric cohort (=54) were profiled using the 16S rRNA gene and ITS2 amplicon sequencing. 16S rRNA gene amplicon sequencing of oesophageal biopsies from a retrospective paediatric cohort (=96) and shotgun metagenomics data from oesophageal brushings (=88) were employed for genomic signature validation. Bacterial diversity and composition showed substantial differences across oral, oesophageal and gastric fluid samples that were not replicated for fungi, and the presence of reflux led to increased homogeneity in the bacterial component of these three microbiotas. The oral and oesophageal microbiotas were associated with age, sex, history of oesophageal atresia and presence of oesophageal metaplasia, with the latter characterized by enrichment. Proton pump inhibitor use was associated with increased oral bacterial richness in the gastric fluid, and this correlated with increased levels of gastric pro-inflammatory cytokines. Profiling of oesophageal biopsies from a retrospective paediatric cohort confirmed an increased prevalence in samples with metaplasia. Analysis of metagenome-derived oesophageal genomes identified strain-specific features that were significantly increased in prevalence in samples with metaplasia. enrichment is a signature associated with paediatric oesophageal metaplasia, and proton pump inhibitor use substantially alters the paediatric gastric microenvironment.

Funding
This study was supported by the:
  • University of New South Wales (Award Scientia fellowship)
    • Principle Award Recipient: NataliaCastaño-Rodríguez
  • Cancer Institute NSW (Award 2019/ECF1082)
    • Principle Award Recipient: NataliaCastaño-Rodríguez
  • University of New South Wales (Award Scientia fellowship)
    • Principle Award Recipient: NadeemOmar Kaakoush
  • Cancer Institute NSW (Award 15/CDF/1-11)
    • Principle Award Recipient: NadeemOmar Kaakoush
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000870
2022-09-15
2024-12-14
Loading full text...

Full text loading...

/deliver/fulltext/mgen/8/9/mgen000870.html?itemId=/content/journal/mgen/10.1099/mgen.0.000870&mimeType=html&fmt=ahah

References

  1. Di Pilato V, Freschi G, Ringressi MN, Pallecchi L, Rossolini GM et al. The esophageal microbiota in health and disease. Ann N Y Acad Sci 2016; 1381:21–33 [View Article]
    [Google Scholar]
  2. Kaakoush NO, Castaño-Rodríguez N, Man SM, Mitchell HM. Is Campylobacter to esophageal adenocarcinoma as Helicobacter is to gastric adenocarcinoma?. Trends Microbiol 2015; 23:455–462 [View Article]
    [Google Scholar]
  3. Nardone G, Compare D, Rocco A. A microbiota-centric view of diseases of the upper gastrointestinal tract. Lancet Gastroenterol Hepatol 2017; 2:298–312 [View Article]
    [Google Scholar]
  4. Deshpande NP, Riordan SM, Gorman CJ, Nielsen S, Russell TL et al. Multi-omics of the esophageal microenvironment identifies signatures associated with progression of Barrett’s esophagus. Genome Med 2021; 13:133 [View Article]
    [Google Scholar]
  5. Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 2018; 154:360–373 [View Article]
    [Google Scholar]
  6. Benitez AJ, Hoffmann C, Muir AB, Dods KK, Spergel JM et al. Inflammation-associated microbiota in pediatric eosinophilic esophagitis. Microbiome 2015; 3:23 [View Article] [PubMed]
    [Google Scholar]
  7. Harris JK, Fang R, Wagner BD, Choe HN, Kelly CJ et al. Esophageal microbiome in eosinophilic esophagitis. PLoS One 2015; 10:e0128346 [View Article] [PubMed]
    [Google Scholar]
  8. Laserna-Mendieta EJ, FitzGerald JA, Arias-Gonzalez L, Ollala JM, Bernardo D et al. Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies. Sci Rep 2021; 11:7113 [View Article] [PubMed]
    [Google Scholar]
  9. van Lennep M, Singendonk MMJ, Dall’Oglio L, Gottrand F, Krishnan U et al. Oesophageal atresia. Nat Rev Dis Primers 2019; 5:26 [View Article] [PubMed]
    [Google Scholar]
  10. Krishnan U, Singh H, Tedla N, Leach ST, Kaakoush NO. Presence of gastric pepsinogen in the trachea is associated with altered inflammation and microbial composition. Infect Immun 2020; 88:e00455-20 [View Article]
    [Google Scholar]
  11. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang J-Y et al. British society of gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 2014; 63:7–42 [View Article]
    [Google Scholar]
  12. Haifer C, Paramsothy S, Borody TJ, Clancy A, Leong RW et al. Long-term bacterial and fungal dynamics following oral lyophilized fecal microbiota transplantation in clostridioides difficile infection. mSystems 2021; 6:e00905-20 [View Article]
    [Google Scholar]
  13. Yang R-H, Su J-H, Shang J-J, Wu Y-Y, Li Y et al. Evaluation of the ribosomal DNA internal transcribed spacer (ITS), specifically ITS1 and ITS2, for the analysis of fungal diversity by deep sequencing. PLoS One 2018; 13:e0206428 [View Article] [PubMed]
    [Google Scholar]
  14. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009; 75:7537–7541 [View Article] [PubMed]
    [Google Scholar]
  15. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol 2013; 79:5112–5120 [View Article]
    [Google Scholar]
  16. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:R60 [View Article]
    [Google Scholar]
  17. Knights D, Kuczynski J, Charlson ES, Zaneveld J, Mozer MC et al. Bayesian community-wide culture-independent microbial source tracking. Nat Methods 2011; 8:761–763 [View Article] [PubMed]
    [Google Scholar]
  18. Deshpande NP, Riordan SM, Castaño-Rodríguez N, Wilkins MR, Kaakoush NO. Signatures within the esophageal microbiome are associated with host genetics, age, and disease. Microbiome 2018; 6:227 [View Article] [PubMed]
    [Google Scholar]
  19. Uritskiy GV, DiRuggiero J, Taylor J. MetaWRAP-a flexible pipeline for genome-resolved metagenomic data analysis. Microbiome 2018; 6:158 [View Article] [PubMed]
    [Google Scholar]
  20. Beghini F, McIver LJ, Blanco-Míguez A, Dubois L, Asnicar F et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife 2021; 10:e65088 [View Article] [PubMed]
    [Google Scholar]
  21. Blum M, Chang H-Y, Chuguransky S, Grego T, Kandasaamy S et al. The interPro protein families and domains database: 20 years on. Nucleic Acids Res 2021; 49:D344–D354 [View Article] [PubMed]
    [Google Scholar]
  22. Derrien M, Alvarez A-S, de Vos WM. The gut microbiota in the first decade of life. Trends Microbiol 2019; 27:997–1010 [View Article]
    [Google Scholar]
  23. Lopetuso LR, Severgnini M, Pecere S, Ponziani FR, Boskoski I et al. Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma. PLoS One 2020; 15:e0231789 [View Article] [PubMed]
    [Google Scholar]
  24. Yang L, Lu X, Nossa CW, Francois F, Peek RM et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 2009; 137:588–597 [View Article] [PubMed]
    [Google Scholar]
  25. Yang D, Chen X, Wang J, Lou Q, Lou Y et al. Dysregulated lung commensal bacteria drive interleukin-17B production to promote pulmonary fibrosis through their outer membrane vesicles. Immunity 2019; 50:692–706 [View Article]
    [Google Scholar]
  26. Mortensen SB, Kilian M. Purification and characterization of an immunoglobulin A1 protease from Bacteroides melaninogenicus. Infect Immun 1984; 45:550–557 [View Article] [PubMed]
    [Google Scholar]
  27. Malinverni JC, Silhavy TJ. An ABC transport system that maintains lipid asymmetry in the gram-negative outer membrane. Proc Natl Acad Sci 2009; 106:8009–8014 [View Article]
    [Google Scholar]
  28. Ekiert DC, Bhabha G, Isom GL, Greenan G, Ovchinnikov S et al. Architectures of lipid transport systems for the bacterial outer membrane. Cell 2017; 169:273–285 [View Article]
    [Google Scholar]
  29. Pandey AK, Sassetti CM. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci 2008; 105:4376–4380 [View Article]
    [Google Scholar]
  30. Jackson MA, Goodrich JK, Maxan M-E, Freedberg DE, Abrams JA et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut 2016; 65:749–756 [View Article] [PubMed]
    [Google Scholar]
  31. Shi Y-C, Cai S-T, Tian Y-P, Zhao H-J, Zhang Y-B et al. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease. Genomics Proteomics Bioinformatics 2019; 17:52–63 [View Article]
    [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.000870
Loading
/content/journal/mgen/10.1099/mgen.0.000870
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error